PAHC - PHIBRO ANIMAL HEALTH CORP
52.27
-2.270 -4.343%
Share volume: 212,542
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$54.54
-2.27
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 05-08-2024 | 01-07-2025 | 11-06-2024 | 02-05-2025 | 05-07-2025 | 08-27-2025 | 11-05-2025 | 02-04-2026 | |
| Total revenue | 263.223 M | 273.164 M | 260.432 M | 309.261 M | 347.825 M | 378.697 M | 363.893 M | 373.910 M | |
| Cost of revenue | 183.623 M | 186.014 M | 176.937 M | 207.391 M | 243.257 M | 268.688 M | 244.110 M | 241.254 M | |
| Gross profit | 79.600 M | 87.150 M | 83.495 M | 101.870 M | 104.568 M | 110.009 M | 119.783 M | 132.656 M | |
| 9.48% | -4.19% | 22.01% | 2.65% | 5.20% | 8.88% | 10.75% | |||
| Operating expenses | 59.676 M | 68.734 M | 65.796 M | 76.337 M | 71.053 M | 76.291 M | 68.523 M | 82.330 M | |
| Selling general and admin | 59.676 M | 68.734 M | 65.796 M | 76.337 M | 71.053 M | 76.291 M | 68.523 M | 82.330 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 59.676 M | 68.734 M | 65.796 M | 76.337 M | 71.053 M | 76.291 M | 68.523 M | 82.330 M | |
| 15.18% | -4.27% | 16.02% | -6.92% | 7.37% | -10.18% | 20.15% | |||
| Operating income | 19.924 M | 18.416 M | 17.699 M | 25.533 M | 33.515 M | 33.718 M | 51.260 M | 50.326 M | |
| Ebit | 17.497 M | 11.146 M | 17.261 M | 13.834 M | 39.043 M | 32.457 M | 48.326 M | 48.181 M | |
| Pretax income | 12.922 M | 6.408 M | 9.620 M | 4.838 M | 29.688 M | 23.847 M | 36.267 M | 36.425 M | |
| -50.41% | 50.12% | -49.71% | 513.64% | -19.67% | 52.08% | 0.44% | |||
| Income tax | 4.517 M | 5.656 M | 2.645 M | 1.653 M | 8.808 M | 6.623 M | 9.740 M | 8.966 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 8.405 M | 752.000 K | 6.975 M | 3.185 M | 20.880 M | 17.224 M | 26.527 M | 27.459 M | |
| -91.05% | 827.53% | -54.34% | 555.57% | -17.51% | 54.01% | 3.51% |